BFIC
BMY icon

Bedell Frazier Investment Counselling’s Bristol-Myers Squibb BMY Stock Holding History

Bedell Frazier Investment Counselling’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$275K Sell
4,530
-57
-1% -$3.32K 0.06% 114
2025
Q4 		$247K Buy
+4,587
New +$221K 0.05% 121

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bedell Frazier Investment Counselling's BMY Position: Q1 2026 in Review

Bedell Frazier Investment Counselling reduced its Bristol-Myers Squibb (BMY) stake by 1.2% in Q1 2026, selling an estimated $3.32K and leaving 4,530 shares worth $275K. The position accounts for 0.06% of the portfolio, ranked #114.

Bedell Frazier Investment Counselling first reported a position in BMY in Q4 2025 and has held it in 2 quarters since. 2,529 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Bedell Frazier Investment Counselling held 4,530 shares of Bristol-Myers Squibb worth $275K as of Q1 2026.
  • Bedell Frazier Investment Counselling sold 57 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.32K.
  • Bristol-Myers Squibb made up 0.06% of Bedell Frazier Investment Counselling's portfolio in Q1 2026, its #114 holding.
  • Bedell Frazier Investment Counselling first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 2 quarters since.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Bedell Frazier Investment Counselling's 13F filing for Q1 2026, filed 15 May 2026.